The Kingdom of Saudi Arabia, represented by the Saudi Food and Drug Authority (SFDA), hosted the 1st Meeting of Arab Authorities Controlling Medicines today at the authority’s headquarters in Riyadh.

This meeting comes in implementation of Resolution No. (11) of the Council of Arab Ministers of Health in its (56th) regular session for 2022, as the Kingdom of Saudi Arabia welcomed at that time to host the aforementioned meeting, which is the first of its kind at the Arab level.

His Excellency the CEO of the Saudi Food and Drug Authority (SFDA), Dr. Hisham bin Saad Aljadhey, inaugurated the first Drug Information Association (DIA) Middle East Conference in Riyadh, which will be from 13 to 14 February 2023 in partnership with the SFDA.

Saudi Food & Drug Authority (SFDA) records more than 30,000 applications via Saudi Drug Registration (SDR) System since the launch of its new version in mid-2021. SDR registered more than 8,000 medicinal, herbal and veterinary products, and issued more than 8,000 certificates.

Saudi Food and Drug Authority (SFDA) penalized 45 facilities during December 2022, due to lack of commitment to provide the registered pharmaceutical products to the local market, inform instantly to the movement of the drug in the electronic tracking system, and report on expected shortage or interruption in the supply of pharmaceutical products that have been registered with the Authority.

The Saudi Food and Drug Authority participates in the 6th annual meeting of the Saudi Pharmaceutical Society "SIPHA". The meeting is held in Dhahran under the patronage of His Royal Highness Prince Saud bin Naif, Governor of the Eastern Region, and in the presence of His Excellency the CEO of SFDA, Dr. Hisham bin Saad Aljadhey, during the period 3-5 January 2023.